Ayurvedic Drug For Anaemia

PHARMACOGNOSTICAL AND CLINICAL STUDY OF BRAHMI (Bacopa monnieri (Linn.)Pennell)CHURNA IN THE MANAGEMENT OF PANDU - NILL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065754

Enrollment

Registered

2024-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patients with classical symptoms of pandu, age group of 20-60 years, Hb level between 6.5-11 g% irrespective of gender, race, occupation and socio-economic status

Exclusion criteria

Exclusion criteria: Patients with age less than 20 years and above 60 years. Patients with infectious disease. Patients with unusual haemolysis. Patients with hereditary elliptocytosis and autoimmune anaemia. Patients having unusual blood loss. Patient with haemoglobinopathies. Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
Mild improvement in the classical signs and symptoms of Anemia. Increase of Hb level by 1g%Timepoint: Review after 30 days,60 days	—

Secondary

Measure	Time frame
Moderate improvement of classical signs and symptoms of Anemia Improvement in the quality of lifeTimepoint: Review after 45 days,60 days	—

Countries

India

Contacts

Public ContactDr. A. VIJAYALAKSHMI

Dr.B.R.K.R. Government Ayurvedic Medical College

vijayalakshmiayanam@gmail.com9849314525

Outcome results